CanadaBuys #SN25005

PMPRB seeks international online guide and database for pharmaceutical pricing and reimbursement

The Patented Medicine Prices Review Board (PMPRB), a Canadian federal agency, is seeking to procure access to an international online guide and database for pharmaceutical pricing and reimbursement. - Government Buyer: - Patented Medicine Prices Review Board (PMPRB) - Office: Chief, Administration and Procurement Services - OEM and Vendor: - IQVIA Solutions Canada Incorporated (only supplier identified as meeting all requirements) - Products/Services Requested: - Subscription-based access to a comprehensive and structured database covering pricing and reimbursement systems, policies, and developments across 31 key global markets - Includes: - Pharma Pricing & Reimbursement International Online Guide (quarterly updates) - Pricing and Reimbursement News Service (weekly updates) - Monthly Editorialized Publication - Comparative Benchmarks Reports (quarterly) - Executive Summaries (quarterly) - Secure online portal access for at least five users - Deliverables in multiple formats: PowerPoint, PDF, Excel - Unique or Notable Requirements: - Coverage of detailed healthcare systems, pricing frameworks, reimbursement processes, policy developments, and benchmarking tools for international comparisons - Regularly updated information (at least quarterly for the database and publications, weekly for news) - Only IQVIA Solutions Canada Inc. identified as meeting all mandatory requirements - Estimated contract value: $223,283.89 USD - No physical products are being procured; focus is on subscription-based information services and deliverables - Place of performance/contracting office: 333 Laurier Ave West, Ottawa, Ontario, K1P 1C1, Canada

Description

The Patented Medicine Prices Review Board (PMPRB) seeks to procure access to a comprehensive international online guide and database for pharmaceutical pricing and reimbursement. The contract involves providing a structured database covering 31 key global markets, a dedicated news service, regular publications, comparative benchmarks, and executive summaries. The procurement is planned as an advance contract award notice with a contract duration of 59 months, and the supplier must demonstrate the ability to deliver detailed, regularly updated information and analysis on global pharmaceutical pricing and reimbursement policies.

View original listing